Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | EIF2AK4 | Q9P2K8 | 9/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.34 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.33 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3877554 | 0.90 | MKNK1 (0.39) | POLBPDCD1CD274MKNK1MKNK2 | |
| SCHEMBL3873971 | 0.89 | GRM2 (0.35) | POLBEIF2AK4SCN9AMKNK1MKNK2 | |
| SCHEMBL3867613 | 0.88 | POLB (0.32) | POLBEIF2AK4SCN9APDCD1CD274 | |
| SCHEMBL3872041 | 0.86 | MKNK1 (0.36) | POLBPDCD1CD274MKNK1MKNK2 | |
| Hydrochloric Acid SCHEMBL3873117 | 0.83 | SCN9A (0.35) | POLBEIF2AK4SCN9AMKNK1MKNK2 | |
| SCHEMBL3877558 | 0.79 | MKNK1 (0.34) | POLBMKNK1MKNK2 | |
| SCHEMBL3873973 | 0.79 | GRM2 (0.32) | POLB | |
| SCHEMBL3865934 | 0.78 | MKNK1 (0.40) | MKNK1MKNK2 | |
| SCHEMBL3871263 | 0.76 | PIK3CA (0.41) | MKNK1MKNK2PIK3CA | |
| Hydrochloric Acid SCHEMBL3864674 | 0.76 | FLT3 (0.38) | POLBSCN9AMKNK1MKNK2PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |